Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Total Non-Current Liabilities (2024)

Kairos Pharma (KAPA) has disclosed Total Non-Current Liabilities for 1 consecutive years, with $992000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Total Non-Current Liabilities changed N/A year-over-year to $992000.0, compared with a TTM value of $992000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $992000.0, changed N/A over the prior year.
  • Total Non-Current Liabilities was $992000.0 for Q4 2024 at Kairos Pharma, down from $1.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.7 million in Q3 2024 and bottomed at $992000.0 in Q4 2024.